eyeforpharma Barcelona 2020
March 31 – 2 April
#efpbarca
Where pharma comes to Life
The 18th annual eyeforpharma Barcelona event has launched with the announcement the theme will be a call to find a new kind of leadership – one that is authentic, all about data-driven decision-making, regulatory-grade access, value-based access and empowering medical on the front line.
“Our once-straightforward industry has, like evolution itself, broadened into a wide tapestry of species designed to explore every habitat. New varieties are finally blooming, spreading their wings. New partnerships are heralding new types of offspring. It is a rich and wonderful time to be working here. Come and celebrate the Cambrian Explosion of our industry – and figure out how to be a perfectly adapted organism.” Paul Simms, Chairman, eyeforpharma
4 essential themes for 2020
Authentic Leadership:
Ensure integrity and accuracy in decision-making and portfolio design. Gain healthcare’s trust through medically-driven content, customer innovation and holistic patient solutions
Hit Commercial Goals:
Turn HCPs into influencers and inspire patient champions. Use content, education, empowerment and open innovation to harness external relationships
From Drugs to Treatments:
Use cloud platforms, data insights and JVs with start-ups to generate a new suite of digital products, value-added services and cell & gene therapies. Go from druggable & reactive to curable & preventative
Digitise Evidence:
Prepare a superior mix of virtual clinical trials and regulatory-grade RWE to gain authorisation, widen access, boost launch and drive patient outcomes
At this year’s event the start-up health challenge returns. Our hand-selected health entrepreneurs take to the stage for a grand elevator pitch battle. Who is the most inspirational? You choose the winner!
Highlighted Speakers include
Kris Sterkens, Company Group Chairman, Janssen EMEA, Janssen
Iris Beck-Codne, EVP, Global Brand & Communications, Teva
Chris Round, EVP, Head of International Operations & Global Core Franchises, Merck
Jeffrey Wren, EVP, Neurology Patient Value Head, UCB
Jassi Chadha, CEO, Axtria
Colin Sims, EVP, Strategy, Kyowa Kirin International
Badhri Srinivasan, Head, Global Development Operations, Novartis
“eyeforpharma Barcelona is regarded in Janssen as a critical, must-attend. Every year.”
Kris Sterkens, Company Group Chairman, EMEA